th Conference on Retroviruses and Opportunistic Infections ARV Therapies and Therapeutic Strategies A CME Newsletter

Until recently, for asymptomatic patients with established disease, providers generally started antiretroviral therapy (ART) when the CD4+ count fell below 350 cells/mm3. However, the DHHS and IAS-USA treatment guidelines now recommend individualizing the decision to initiate ART for those with higher CD4+ counts, rather than generally deferring therapy as… CONTINUE READING